MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Location
Founded
1989-12-19
Website
Risk Signals
4962 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2024-08-21 (market.us)
Biosensors Market Size, Share, Demand
Biosensors Market size is expected to be worth around USD 63 billion by 2032 from USD 27.2 billion in 2022, at a CAGR of 9% during 2022-2032.
Read more
2024-06-26 (eldiariomx.com)
There is a shortage of glucose sensors; diabetics demand a solution from Medtronic
Ciudad Victoria, Tam.- Mexican diabetes patients face a serious shortage problem; This is how the user makes it known through Change.org
Read more
2024-01-19 (industrytoday.co.uk)
Hemodialysis Machine Market Analysis,Demand,Trends and Forecast 2030
Hemodialysis Machine Market Analysis,Demand,Trends and Forecast 2030
Read more
2023-11-24 (industrytoday.co.uk)
Infusion Alarm Market Analysis, Demand, Trends and Forecast 2029
Infusion Alarm Market Analysis, Demand, Trends and Forecast 2029
Read more
2023-01-27 (massdevice.com)
ResMed revenue up 16% as it boosts production amid CPAP shortages
ResMed reported Street-beating Q2 results as it boosted production to meet the demand created by Philips' massive respiratory device recall.
Read more
2021-06-03 (sdtimes.com)
Creating a citizen development program at Medtronic - SD Times
Three key lessons learned from creating the citizen development program at medical device provider Medtronic.
Read more
2018-12-26 (barrons.com)
Abbott Laboratories and Medtronic Expect Stent Demand to Stay Steady
Stent manufacturers such as Abbott Laboratories and Medtronic still expect demand for stents to remain steady.
Read more
2015-09-01 (medtronic.com)
Medtronic, Inc. Announces Results of the Registered ...
Press Release View printer-friendly version << Back. PDF Version. Medtronic, Inc. Announces Results of the Registered Exchange Offers for Certain of Its Senior Notes. DUBLIN- September1, 2015- Medtronic plc( the `` Company '')( NYSE: MDT) today
Read more
(dicardiology.com)
Medtronic Ends Sales of HVAD Ventricular Assist System |
Medtronic announced in June it was stopping the sale and distribution of the Medtronic Heartware HVAD left ventricular assist device (LVAD). On June 3, the company notified physicians to cease new implants of the HVAD System and transition to an alternative means of durable mechanical circulatory support. Its primary competitor in the LVAD market, Abbott, also announced it has the capacity to meet increased demand for LVADs as Medtronic leaves the market. Medtronic initiated the action in light of a growing body of observational clinical comparisons indicating a higher frequency of neurological adverse events, including stroke and mortality with the HVAD system as compared to other circulatory support devices available to patients. Considering these findings and the availability of alternative devices, Medtronic said it made the decision to stop the distribution and sale of the HVAD System, consistent with its commitment to prioritize patient safety. `` The Medtronic Mission guides us to always do what is in
Read more
(logistiek.nl)
Frank Schaapveld is Supply Chain Professional 2011
Supply chain director Frank Schaapveld of Medtronic takes away the title of Supply Chain Professional 2011. This was announced today via Twitter. Schaapveld has fulfilled various supply chain functions within Medtronic since 2003.
Read more
(csrwire.com)
CSRWire - Everstream Analytics & Medtronic Recognized by Supply & Demand Chain Executive
The award recognizes Everstream’s UFLPA Risk Solution created to help companies uncover risk and demonstrate compliance with current and emerging forced labor requirements such as the Uyghur Forced Labor Prevention Act (UFLPA).
Read more